<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014048</url>
  </required_header>
  <id_info>
    <org_study_id>UTampere</org_study_id>
    <nct_id>NCT05014048</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation for the Prevention of Acute Respiratory Infections: a RCT in Young Finnish Men</brief_title>
  <official_title>Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infection: a Randomized, Double-blinded and Plasebo Controlled Trial Among Young Finnish Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Finnish Defense Forces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D intervention effects on the prevention of acute respiratory tract infections among&#xD;
      Young Finnish Men&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days off duty due to acute respiratory tract infections</measure>
    <time_frame>4 months</time_frame>
    <description>The number of Days off Duty recommended by Health care personnel will be calculated in order to show the severity and last of the disease. By that it could be estimated how the disease will effect on duty service.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days off duty due to musculoskeletal disorders</measure>
    <time_frame>4 months</time_frame>
    <description>The number of days off Duty because of musculoskeletal disorders will be index for outcome. The index will be compared between plasebo and intervention group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aerobic and muscular fitness</measure>
    <time_frame>4 months</time_frame>
    <description>Used test are Cooper-test for aerobic and Finnish military fitness test for muscular fitness performance. The index will be compared between plasebo and intervention group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Respiratory Tract Infections</condition>
  <arm_group>
    <arm_group_label>vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 mikrog vitamin D3 daily, 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>20 mikrog vitamin D3 daily</description>
    <arm_group_label>vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria;&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  18-29 years of age&#xD;
&#xD;
          -  examined as Healthy according to Finnish Military Health Care regulations&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  age &gt; 30 yrs&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ilkka laaksi, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tampere, Finland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ilkka Tuomas Laaksi, MD PhD</last_name>
    <phone>+358503479326</phone>
    <email>ilkka.laaksi@tuni.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Finnish Defence Forces</name>
      <address>
        <city>HÃ¤meenlinna</city>
        <zip>13210</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilkka Tuomas Laaksi, MDPhD</last_name>
      <phone>+358503479326</phone>
      <email>ilkka.laaksi@tuni.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University</investigator_affiliation>
    <investigator_full_name>Ilkka Laaksi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

